Showing results (21-30 of 116) with videos related to
Sort By:
Pageof 12
Cancer Treatment Reports|April 1, 1982
Anatomic substages of stage IIIA Hodgkin's disease: followup of a collaborative studyR S Stein, H M Golomb, P H Wiernik, et al.Cancer|December 1, 1987
Malignant lymphomas of follicular center cell origin in man. VI. Large cleaved cell lymphomaR S Stein, M J Magee, R K Lenox, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patientsJ P Greer, W R Macon, R E Lamar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphomaJ P Greer, M C Kinney, R D Collins, et al.The American Journal of Medicine|April 1, 1988
Re-treatment of aplastic anemia with antithymocyte globulin or antilymphocyte serumR T Means, S B Krantz, E N Dessypris, et al.Annals of Internal Medicine|November 1, 1986
Non-Hodgkin's lymphoma after treatment of Hodgkin's disease: association with Epstein-Barr virusA F List, J P Greer, J B Cousar, et al.Blood|June 1, 1985
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot studyS N Wolff, J Marion, R S Stein, et al.Hematological Oncology|July 1, 1990
Clinical features associated with transformation of cerebriform T-cell lymphoma to a large cell processJ P Greer, K E Salhany, J B Cousar, et al.Leukemia & Lymphoma|November 8, 2001
Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapyR S Stein, S N Wolff, J P Greer, et al.Cancer|July 15, 1991
Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphomaM L McMaster, J P Greer, S N Wolff, et al.Pageof 12